Patents by Inventor Yoshinori Asakawa

Yoshinori Asakawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNF-? production inhibitor comprising kavalactone as an active ingredient
    Patent number: 7199152
    Abstract: The present invention provides a TNF-? production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-? production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-?, the agent containing a kavalactone as an active ingredient.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 3, 2007
    Assignee: Meiji Dairies Corporation
    Inventors: Yoshinori Asakawa, Sachiko Okabe, Masashi Yamada, Yukie Suma, Hiroto Suzuki, Masayuki Uchida, Natsuko Murata
  • TNF-alpha production inhibitor comprising kavalactone as an active ingredient
    Publication number: 20060121132
    Abstract: The present invention provides a TNF-? production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-? production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-?, the agent containing a kavalactone as an active ingredient.
    Type: Application
    Filed: January 20, 2006
    Publication date: June 8, 2006
    Applicant: MEIJI DAIRIES CORPORATION
    Inventors: Yoshinori Asakawa, Sachiko Okabe, Masashi Yamada, Yukie Suma, Hiroto Suzuki, Masayuki Uchida, Natsuko Murata
  • TNF-&agr; production inhibitor comprising kavalactone as an active ingredient
    Patent number: 6608105
    Abstract: The present invention provides a TNF-&agr; production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-&agr; production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-&agr;, the agent containing a kavalactone as an active ingredient.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: August 19, 2003
    Assignee: Meiji Dairies Corporation
    Inventors: Yoshinori Asakawa, Sachiko Okabe, Masashi Yamada, Yukie Suma, Hiroto Suzuki, Masayuki Uchida, Natsuko Murata
  • TNF-alpha production inhibitor comprising kavalactone as an active ingredient
    Publication number: 20020173540
    Abstract: The present invention provides a TNF-&agr; production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-&agr; production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-&agr;, the agent containing a kavalactone as an active ingredient.
    Type: Application
    Filed: July 1, 2002
    Publication date: November 21, 2002
    Applicant: MEIJI DAIRIES CORPORATION
    Inventors: Yoshinori Asakawa, Sachiko Okabe, Masashi Yamada, Yukie Suma, Hiroto Suzuki, Masayuki Uchida, Natsuko Murata
  • TNF-alpha production inhibitor comprising kavalactone as an active ingredient
    Publication number: 20020077351
    Abstract: The present invention provides a TNF-&agr; production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-&agr; production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-&agr;, the agent containing a kavalactone as an active ingredient.
    Type: Application
    Filed: August 30, 2001
    Publication date: June 20, 2002
    Applicant: MEIJI DAIRIES CORPORATION
    Inventors: Yoshinori Asakawa, Sachiko Okabe, Masashi Yamada, Yukie Suma, Hiroto Suzuki, Masayuki Uchida, Natsuko Murata
  • Aroma composition
    Patent number: 4720354
    Abstract: There is provided an aroma composition containing 1,5,8,8-tetramethylbicyclo[8.1.0]undec-5-en-2-one. This sesquiterpene ketone has an aroma reminiscent of a variety of odors based on the strong powdery, woody note and furthermore has high diffusivity and retentivity and accords well with a number of perfume, fragrance and flavor materials.
    Type: Grant
    Filed: November 15, 1985
    Date of Patent: January 19, 1988
    Assignee: Kuraray Co., Ltd.
    Inventor: Yoshinori Asakawa
  • Aroma composition
    Patent number: 4659509
    Abstract: There is provided an aroma composition containing a sesquiterpene alcohol having the hexahydroindane skeleton. Such sesquiterpene alcohol has a fantastic aroma reminiscent of a variety of odors based on the woody note and powdery green note and furthermore has high diffusivity and retentivity and accords well with a number of perfume and fragrance materials and flavor materials.
    Type: Grant
    Filed: April 17, 1985
    Date of Patent: April 21, 1987
    Assignee: Kuraray Co., Ltd.
    Inventor: Yoshinori Asakawa